Literature DB >> 8651202

Alendronate-induced ulcerative esophagitis.

M F Abdelmalek, D D Douglas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651202

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  6 in total

1.  Gastric hemorrhage and ulceration in hiatal hernia sac associated with alendronate.

Authors:  P S Kaye
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

Review 2.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 3.  What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

4.  The hydrogen sulfide donor, Lawesson's reagent, prevents alendronate-induced gastric damage in rats.

Authors:  L A D Nicolau; R O Silva; S R B Damasceno; N S Carvalho; N R D Costa; K S Aragão; A L R Barbosa; P M G Soares; M H L P Souza; J V R Medeiros
Journal:  Braz J Med Biol Res       Date:  2013-08-16       Impact factor: 2.590

5.  Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis.

Authors:  Yeesuk Kim; Yuxi Tian; Jianxiao Yang; Vojtech Huser; Peng Jin; Christophe G Lambert; Hojun Park; Seng Chan You; Rae Woong Park; Peter R Rijnbeek; Mui Van Zandt; Christian Reich; Rohit Vashisht; Yonghui Wu; Jon Duke; George Hripcsak; David Madigan; Nigam H Shah; Patrick B Ryan; Martijn J Schuemie; Marc A Suchard
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

6.  Synthesis of composite magnetic nanoparticles Fe3O4 with alendronate for osteoporosis treatment.

Authors:  Ming-Song Lee; Chao-Ming Su; Jih-Chao Yeh; Pei-Ru Wu; Tien-Yao Tsai; Shyh-Liang Lou
Journal:  Int J Nanomedicine       Date:  2016-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.